These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18593681)

  • 1. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization.
    Davis EM; Christensen CM; Nystrom KK; Foral PA; Destache C
    Am J Health Syst Pharm; 2008 Jul; 65(14):1347-57. PubMed ID: 18593681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY Study.
    Bossi AC; Veronesi G; Poerio CS; Braus A; Madaschi S; Destro M; Ferraro B; Gilberti L; Sganzerla P; Davis EM
    Curr Diabetes Rev; 2016; 12(4):460-467. PubMed ID: 26245310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse satisfaction using insulin pens in hospitalized patients.
    Davis EM; Bebee A; Crawford L; Destache C
    Diabetes Educ; 2009; 35(5):799-809. PubMed ID: 19633151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes.
    Bastian MD; Wolters NE; Bright DR
    Consult Pharm; 2011 Jun; 26(6):426-9. PubMed ID: 21628141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vials.
    Asche CV; Luo W; Aagren M
    Curr Med Res Opin; 2013 Oct; 29(10):1287-96. PubMed ID: 23865725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh.
    Kamrul-Hasan ABM; Hannan MA; Alam MS; Rahman MM; Asaduzzaman M; Mustari M; Paul AK; Kabir ML; Chowdhury SR; Talukder SK; Sarkar S; Hannan MA; Islam MR; Iftekhar MH; Robel MAB; Selim S
    BMC Endocr Disord; 2023 Feb; 23(1):37. PubMed ID: 36782190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing accuracy of insulin pens versus conventional syringes and vials.
    Luijf YM; DeVries JH
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S73-7. PubMed ID: 20515311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vials and prefilled pens of a rapid-acting insulin analog on pharmacy budgets in a long-term care setting.
    Eby EL; Smolen LJ; Pitts AC; Krueger LA; Andrews JS
    Consult Pharm; 2014 Dec; 29(12):813-22. PubMed ID: 25521657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.
    Eby EL; Boye KS; Lage MJ
    J Med Econ; 2013 Oct; 16(10):1231-7. PubMed ID: 23834480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM; Borgman SK
    Am J Ther; 2013; 20(6):694-702. PubMed ID: 21768872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Budget impact analysis of insulin therapies and associated delivery systems.
    Lee LJ; Smolen LJ; Klein TM; Foster SA; Whiteman D; Jorgenson JA; Hultgren S
    Am J Health Syst Pharm; 2012 Jun; 69(11):958-65. PubMed ID: 22610028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R; de Beaufort C; Hoey H; Anderson B
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pens vs. vials and syringes: the pharmacist's role in individualizing therapy.
    Honebrink AN; Peters CR; Bright DR
    Consult Pharm; 2011 Jul; 26(7):491-3. PubMed ID: 21729850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.